Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04891224 · ClinicalTrials.gov registry record · NA
Use of a Digitally Enabled App With Clinical Team Interface in the Management of Depression
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT04891224 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 89 participants.
The verdict
NCT04891224, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
This study was conducted to understand the use of a mobile app (titled Pathway) to help patients track depression symptoms, medications, side effects, and goals in addition to the usual care with their doctor. Investigators compared the effect of the app over 6 months and examine whether the app can increase engagement between patients and their doctor and help in the management of illnesses as patients started a new treatment for depression. The investigators hoped that using an app to facilitate management of depression symptoms, medication use, and side effects help patients and their providers understand their response to medications and lead to better response and improvements in depression.
Interventions
- OTHER Pathway Platform mobile app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2021-02-19 |
| Est. Completion | 2023-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04891224
The ClinicalTrials.gov registry entry for NCT04891224 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pathway Platform mobile app is the first listed.
NCT04891224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04891224 about?
NCT04891224 is a clinical study titled "Use of a Digitally Enabled App With Clinical Team Interface in the Management of Depression". This study was conducted to understand the use of a mobile app (titled Pathway) to help patients track depression symptoms, medications, side effects, and goals in addition to the usual care with their doctor. Investigators compared the effect of the app over 6 months and examine whether the app can...
What is the current status of trial NCT04891224?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2021-02-19. Estimated completion is 2023-01-30.
What interventions are being tested in trial NCT04891224?
The interventions under investigation include: Pathway Platform mobile app (OTHER).
Who is sponsoring clinical trial NCT04891224?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.